Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;105(28-29):501-6.
doi: 10.3238/arztebl.2008.0501. Epub 2008 Jul 14.

Trend reversal in the frequency of mycoses in hematological neoplasias: autopsy results from 1976 to 2005

Affiliations

Trend reversal in the frequency of mycoses in hematological neoplasias: autopsy results from 1976 to 2005

Konrad Donhuijsen et al. Dtsch Arztebl Int. 2008 Jul.

Abstract

Introduction: Fungal infections of internal organs are a major complication for patients with hematological neoplasias. For more than 20 years, the frequency of such mycoses has been increasing with the aggressiveness of tumor treatment.

Methods: Autopsy findings over a 30-year period (1976 to 2005) from a single institution (Institute of Pathology, University of Essen) were retrospectively classified according to basic disease, frequency of mycoses, kind of mycoses, organs involved, hematopoietic transplantation, and cause of death.

Results: 340 of 1591 autopsied patients with hematological neoplasias (21.4%) revealed an invasive mycosis. The proportion increased from about 10% before 1980 to some 30% in the 1990s but fell to 21% by 2005. The frequency of mycoses decreased significantly both for transplanted patients (from 47.5% to 30.3%) and for non-transplanted patients (from 29.8% to 16.4%). The rate of deaths due to mycosis also decreased. The relative frequency of candidal mycoses went down, while aspergilloses predominated. The organ most frequently involved was the lung.

Discussion: The autopsy results signal a trend reversal in the leading complication of the treatment of hematological neoplasias and lend support to the assumption that antimycotic strategies are having a positive effect.

Keywords: autopsy; hematological neoplasia; leukemia; lymphoma; mycosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Five-year frequency of invasive mycoses in hematological neoplasias. Significant group differences and 95% confidence intervals (mean 21.4%; 340 of 1591 patients).
Figure 2
Figure 2
Frequency of deep mycoses in different neoplasias. Changes with time
Figure 3
Figure 3
Five-year mycosis rate after hematological transplantations. Significant group differences and 95% confidence intervals (mean 36%; 96 of 267 patients).
Figure 4
Figure 4
Mycosis rate in non-transplanted patients with hematological neoplasias. Significant group differences and 95% confidence intervals (mean 18.4%; 244 of 1324 patients).

References

    1. Viscoli C, Girmenia C, Marinus A, et al. The Invasive Fungal Infection Group of the EORTC. Candidemia in cancer patients. A prospective, multicenter surveillance study in Europe by the the Invasive Fungal Infection Group (IFIG) of the European Organization für Research and Treatment of Cancer (EORTC) Clin Infect Dis. 1999;28:1071–1079. - PubMed
    1. Ruhnke M, Boehme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology- and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Ann Hematol. 2003;82:141–148. - PubMed
    1. Herbrecht R, Denning DW, Petterson TF, et al. Voriconazole versus Amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–415. - PubMed
    1. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of Caspofungin and Amphotericin B for invasive candidiasis. N Engl J Med. 2002;347:2020–2029. - PubMed
    1. De Pauw BE, Donnelly JP. Prophylaxis and aspergillosis - has the principle been proven? N Engl J Med. 2007;356:409–411. - PubMed